Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 5
2006 2
2007 1
2008 3
2009 3
2010 3
2011 5
2012 6
2013 3
2014 2
2015 4
2016 2
2017 5
2018 9
2019 8
2020 4
2021 8
2022 11
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. Niihara Y, et al. Among authors: hsu ll. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Free article. Clinical Trial.
Prioritizing Sickle Cell Disease.
Hsu LL, Hooper WC, Schieve LA. Hsu LL, et al. Pediatrics. 2022 Dec 1;150(6):e2022059491. doi: 10.1542/peds.2022-059491. Pediatrics. 2022. PMID: 36126160 Free PMC article. No abstract available.
Timely Care for Sickle Cell.
Colla JS, Kotini-Shah P, Brown SB, Hsu LL. Colla JS, et al. Among authors: hsu ll. Jt Comm J Qual Patient Saf. 2017 Mar;43(3):113-115. doi: 10.1016/j.jcjq.2016.12.007. Epub 2017 Jan 13. Jt Comm J Qual Patient Saf. 2017. PMID: 28334589 No abstract available.
Summer Camps for Children with Sickle Cell Disease.
Narcisse L, Walton EA, Hsu LL. Narcisse L, et al. Among authors: hsu ll. Ochsner J. 2018 Winter;18(4):358-363. doi: 10.31486/toj.18.0045. Ochsner J. 2018. PMID: 30559621 Free PMC article. Review.
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Hankins JS, Brambilla D, Potter MB, Kutlar A, Gibson R, King AA, Baumann AA, Melvin C, Gordeuk VR, Hsu LL, Nwosu C, Porter JS, Alberts NM, Badawy SM, Simon J, Glassberg JA, Lottenberg R, DiMartino L, Jacobs S, Fernandez ME, Bosworth HB, Klesges LM, Shah N. Hankins JS, et al. Among authors: hsu ll. Blood Adv. 2023 Dec 12;7(23):7190-7201. doi: 10.1182/bloodadvances.2023010670. Blood Adv. 2023. PMID: 37738155 Free PMC article. Clinical Trial.
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
Casella JF, Barton BA, Kanter J, Black LV, Majumdar S, Inati A, Wali Y, Drachtman RA, Abboud MR, Kilinc Y, Fuh BR, Al-Khabori MK, Takemoto CM, Salman E, Sarnaik SA, Shah N, Morris CR, Keates-Baleeiro J, Raj A, Alvarez OA, Hsu LL, Thompson AA, Sisler IY, Pace BS, Noronha SA, Lasky JL 3rd, de Julian EC, Godder K, Thornburg CD, Kamberos NL, Nuss R, Marsh AM, Owen WC, Schaefer A, Tebbi CK, Chantrain CF, Cohen DE, Karakas Z, Piccone CM, George A, Fixler JM, Singleton TC, Moulton T, Quinn CT, de Castro Lobo CL, Almomen AM, Goyal-Khemka M, Maes P, Emanuele M, Gorney RT, Padgett CS, Parsley E, Kronsberg SS, Kato GJ, Gladwin MT. Casella JF, et al. Among authors: hsu ll. JAMA. 2021 Apr 20;325(15):1513-1523. doi: 10.1001/jama.2021.3414. JAMA. 2021. PMID: 33877274 Free PMC article. Clinical Trial.
94 results